Overview

The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy

Status:
Unknown status

Trial end date:
2019-12-01

Target enrollment:

Participant gender:

Summary

This study evaluates the efficacy and safety of Udenafil dosed once a day in patients with erectile dysfunction after bilateral nerve-sparing radical prostatectomy.

Phase:

Phase 4

Details

Lead Sponsor:

Samsung Medical Center

Collaborator:

Dong-A ST Co., Ltd.

Treatments:

Udenafil